1. Amezaga-Fernández I, Aguirre-Urizar JM, Suárez-Peñaranda JM, Chamorro-Petronacci C, Lafuente-Ibáñez de Mendoza I, Marichalar-Mendia X, et al. Epidemiological, clinical, and prognostic analysis of oral squamous cell carcinoma diagnosed and treated in a single hospital in Galicia (Spain): a retrospective study with 5-year follow-up. Med Oral Patol Oral Cir Bucal. 2024;29:e36-43.

https://doi.org/10.4317/medoral.26047

PMid:37330964 PMCid:PMC10765332

2. Schwimmer E. Die idiopathischen Schlimhautplaques des Mundhöhle (Leukoplakia buccalis). Arch Derm Syphilol. 1877;9:511-70.

PMid:

3. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575-80.

https://doi.org/10.1111/j.1600-0714.2007.00582.x

PMid:17944749 

4. Mello FW, Miguel AFP, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra ENS, et al. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis. J Oral Pathol Med. 2018;47:633-40.

https://doi.org/10.1111/jop.12726

PMid:29738071 

5. Zhang C, Li B, Zeng X, Hu X, Hua H. The global prevalence of oral leukoplakia: a systematic review and meta-analysis from 1996 to 2022. BMC Oral Health. 2023;23:645.

https://doi.org/10.1186/s12903-023-03342-y

PMid:37670255 PMCid:PMC10481497

6. Aguirre-Urizar JM. Proliferative multifocal leukoplakia better name that proliferative verrucous leukoplakia. World J Surg Oncol. 2011;9:122.

https://doi.org/10.1186/1477-7819-9-122

PMid:21985464 PMCid:PMC3206443

7. Lafuente Ibáñez de Mendoza I, Lorenzo Pouso AI, Aguirre Urízar JM, Barba Montero C, Blanco Carrión A, Gándara Vila P, et al. Malignant development of proliferative verrucous/multifocal leukoplakia: A critical systematic review, meta-analysis and proposal of diagnostic criteria. J Oral Pathol Med. 2022;51:30-8.

https://doi.org/10.1111/jop.13246

PMid:34558734 

8. Abdul NS, Rashdan Y, Alenezi N, Alenezi M, Mohsin L, Hassan A. Association Between Oral Microbiota and Oral Leukoplakia: A Systematic Review. Cureus. 2024;16:e52095.

https://doi.org/10.7759/cureus.52095

PMid:38344503

9. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6:963-8.

https://doi.org/10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q

PMid:13094644 

10. Watson JD, Crick FH. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature. 1953;171:737-8.

https://doi.org/10.1038/171737a0

PMid:13054692 

11. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996;56:2488-92.

https://doi.org/10.1016/S0194-5998(96)80631-0

PMid:8653682 

12. Cai X, Zhang J, Zhang H, Li T. Biomarkers of malignant transformation in oral leukoplakia: from bench to bedside. J Zhejiang Univ Sci B. 2023;24:868-82.

https://doi.org/10.1631/jzus.B2200589

PMid:37752089 PMCid:PMC10522567

13. Mao L, Lee JS, Fan YH, Ro JY, Batsakis JG, Lippman S, et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med. 1996;2:682-5.

https://doi.org/10.1038/nm0696-682

PMid:8640560 

14. López M, Aguirre JM, Cuevas N, Anzola M, Videgain J, Aguirregaviria J, et al. Gene promoter hypermethylation in oral rinses of leukoplakia patients--a diagnostic and/or prognostic tool?. Eur J Cancer. 2003;39:2306-9.

https://doi.org/10.1016/S0959-8049(03)00550-1

PMid:14556921 

15. Odell EW. Aneuploidy and loss of heterozygosity as risk markers for malignant transformation in oral mucosa. Oral Dis. 2021;27:1993-2007.

https://doi.org/10.1111/odi.13797

PMid:33577101 

16. Guimarães LM, Diniz MG, Rogatto SR, Gomez RS, Gomes CC. The genetic basis of oral leukoplakia and its key role in understanding oral carcinogenesis. J Oral Pathol Med. 2021;50:632-8.

https://doi.org/10.1111/jop.13140

PMid:33217066 

17. Pindborg JJ, Renstrup G, Poulsen HE, Silverman S JR. Studies in oral leukoplakias. V. Clinical and histologic signs of malignancy. Acta Odontol Scand. 1963;21:407-14.

https://doi.org/10.3109/00016356309028203

PMid:14110648 

18. Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol. 1978;46:518-39.

https://doi.org/10.1016/0030-4220(78)90383-3

PMid:280847 

19. Axéll T, Pindborg JJ, Smith CJ, van der Waal I. Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med. 1996;25:49-54.

https://doi.org/10.1111/j.1600-0714.1996.tb00191.x

PMid:8667255 

20. Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, González-Moles MÁ, Kerr AR, et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27:1862-80.

https://doi.org/10.1111/odi.13704

PMid:33128420 

21. Aguirre-Urizar JM, Lafuente-Ibáñez de Mendoza I, Warnakulasuriya S. Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years. Oral Dis. 2021;27:1881-95.

https://doi.org/10.1111/odi.13810

PMid:33606345 

22. Hansen LS, Olson JA, Silverman S Jr. Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg Oral Med Oral Pathol. 1985;60:285-98.

https://doi.org/10.1016/0030-4220(85)90313-5

PMid:3862042 

23. van der Waal I. Oral leukoplakia, the ongoing discussion on definition and terminology. Med Oral Patol Oral Cir Bucal. 2015;20:e685-92.

https://doi.org/10.4317/medoral.21007

PMid:26449439 PMCid:PMC4670248

24. Odell E, Kujan O, Warnakulasuriya S, Sloan P. Oral epithelial dysplasia: Recognition, grading and clinical significance. Oral Dis. 2021;27:1947-76.

https://doi.org/10.1111/odi.13993

PMid:34418233 

25. Aguirre-Urizar JM, Warnakulasuriya S. The significance of oral epithelial dysplasia in the clinical management of oral potentially malignant disorders. Int J Oral Maxillofac Surg. 2023;52:510-1.

https://doi.org/10.1016/j.ijom.2022.06.024

PMid:36050141 

26. Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol. 2006;42:987-93.

https://doi.org/10.1016/j.oraloncology.2005.12.014

PMid:16731030 

27. Sperandio M, Warnakulasuriya S, Soares AB, Passador-Santos F, Mariano FV, Lima CSP, et al. Oral epithelial dysplasia grading: Comparing the binary system to the traditional 3-tier system, an actuarial study with malignant transformation as outcome. J Oral Pathol Med. 2023;52:418-25.

https://doi.org/10.1111/jop.13365

PMid:36177736 

28. Mahmood H, Bradburn M, Rajpoot N, Islam NM, Kujan O, Khurram SA. Prediction of malignant transformation and recurrence of oral epithelial dysplasia using architectural and cytological feature specific prognostic models. Mod Pathol. 2022;35:1151-9.

https://doi.org/10.1038/s41379-022-01067-x

PMid:35361889 PMCid:PMC9424112

29. Wils LJ, Poell JB, Peferoen LAN, Evren I, Brouns ER, de Visscher JGAM, et al. The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia. J Oral Pathol Med. 2023;52:930-8.

https://doi.org/10.1111/jop.13483

PMid:37749621 

30. Shephard AJ, Bashir RMS, Mahmood H, Jahanifar M, Minhas F, Raza SEA, et al. A fully automated and explainable algorithm for predicting malignant transformation in oral epithelial dysplasia. NPJ Precis Oncol. 2024;8:137.

https://doi.org/10.1038/s41698-024-00624-8

PMid:38942998 PMCid:PMC11213925

31. Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:612-27.

https://doi.org/10.1016/j.oooo.2017.12.011

PMid:29396319 

32. Pimenta-Barros LA, Ramos-García P, González-Moles MÁ, Aguirre-Urizar JM, Warnakulasuriya S. Malignant transformation of oral leukoplakia: Systematic review and comprehensive meta-analysis. Oral Dis. 2025;31:69-80.

https://doi.org/10.1111/odi.15140

PMid:39314164 PMCid:PMC11808172

33. Birkeland AC, Kademani D, Moore MG, Blair EA. Practice patterns for initial management of oral leukoplakia amongst otolaryngologists and oral and maxillofacial surgeons. Oral Oncol. 2023;139:106341.

https://doi.org/10.1016/j.oraloncology.2023.106341

PMid:36842197 

34. Pentenero M, Sutera S, Lodi G, Bagan JV, Farah CS. Oral leukoplakia diagnosis and treatment in Europe and Australia: Oral Medicine Practitioners' attitudes and practice. Oral Dis. 2023;29:3214-22.

https://doi.org/10.1111/odi.14301

PMid:35792047 

35. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev. 2006;1:CD001829.

https://doi.org/10.1002/14651858.CD001829.pub3

PMid:17054142

36. van der Waal I, Axéll T. Oral leukoplakia: a proposal for uniform reporting. Oral Oncol. 2002;38:521-6.

https://doi.org/10.1016/S1368-8375(01)00125-7

PMid:12167428 

37. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42:461-74.

https://doi.org/10.1016/j.oraloncology.2005.08.011

PMid:16316774 

38. Lombardi N, Arduino PG, Lampiano M, Gambino A, Broccoletti R, Varoni EM, Lodi G. Surgical treatment compared with "wait and see" in patients affected by oral leukoplakia to prevent oral cancer: Preliminary data from a multicenter randomized controlled trial. Oral Dis. 2024.

https://doi.org/10.1111/odi.15058

PMid:38938085 

39. Kerr AR, Lodi G. Management of oral potentially malignant disorders. Oral Dis. 2021;27:2008-25.

https://doi.org/10.1111/odi.13980

PMid:34324758